地层压降,Reservoir pressure decline
1)Reservoir pressure decline地层压降
2)decreasing formation fracturing pressure降低地层破裂压力
3)pressure drop床层压降
1.There is a problem ofpressure drop rising during coker gasoline hydrorefining in the catalyst beds of unit1-B of SINOPEC Guangzhou Company.广州分公司加氢精制(一)B装置在进行焦化汽油加氢精制过程中存在催化剂床层压降升高过快的问题。
2.The influence of the stirrer speed and the blade shape on the fluidization in the stirred gas-solid fluidized beds was experimentally studied by examining the relationship between thepressure drop and superficial gas velocity.在流态化阶段,床层压降保持定值,该定值与搅拌转速和叶片形式没有关系。
3.Thepressure drop and two dimensional temperature profiles of a new hollow cylindrical vinyl acetate synthesis catalyst were measured in packed bed, and active ingredients were maldistributed on the inner and outside surface of this hollow cylinder.实验测定了一种新型的环柱形催化剂活性组分在其内、外表面上不均匀分布的乙烯基乙酸酯合成反应器的床层压降和该催化剂填充床的二维温度分布 ;以压降实验数据代入 Ergun公式计算了环柱形催化剂的当量直径 ds和填充床的传热参数 ,采用正交配置的方法对拟均相二维传热模型进行求解 ,得到床层的径向有效导热系数和壁给热系数。
英文短句/例句
1.Factor Analysis for the Increasing of Pressure Drop in Fixed- bed Reactor of Butylenes Hydration and Corresponding Solution丁烯水合反应器床层压降分析及解决方案
2.Hydrodynamics of Vibrated Fluidized Bed of Mono-component Particles (Ⅰ)──Pressure Drop at Minimum Fluidization单组分颗粒振动流化床的流体力学研究（1）──起始流化时床层压降
3.A Discussion on the Problem of Pressure Drop in the Fixed bed Catalytic Reactor固定床催化反应器床层压强降问题的讨论
4.The inventory of solids in a fluidized bed can easily be found by pressure drop measurements across the bed.流化床内的固定藏量可以用测定床层的压降办法很容易地求得。
5.The Clinical Study of the Impacts of "Tang Zhi Xiao" in Adjusting Blood Sugar, Blood Pressure and Lipid Content;“糖脂消”降糖调脂降压作用的临床研究
6.Clinical Study on Jiangya Powder in Treatment of 300 Hypertension Patients降压散治疗高血压病300例临床研究
7.Influence of Dewatering of Confined Aquifers on Land Subsidence During Deep Excavation深基坑承压含水层降水对地面沉降的影响
8.EXPERIENCE ON REDUCTION OF ORE-DILUTION IN MINING A THIN-BED URANIUM DEPOSIT开采薄层铀矿床中降低贫化率的经验
9.The Clinical Study of the Effect of 7.5% Hypertonic Saline on the Treatment of Intracranial Hypertension;7.5%高渗盐水降颅压作用的临床研究
10.Clinical Epidemiology of the Antihypertensive Efficacy of GITS;拜新同降压疗效的临床流行病学研究
11.blow-down recovery靠降低地层压力采出的油
12.A Model of SOI High Voltage Device with Reduced-field Layer and Partial Substrate带降场层部分衬底SOI高压器件模型
13.Land Subsidence and Compression of Soil Layers in Changzhou Area常州地区地面沉降及地层压缩性研究
14.The influenceof formation temperature decreasing on formation pressure in Sulige Gasfield地层温度的降低对苏里格气田地层压力的影响
15.Clinical Research on Bu Shen Antihypertension Decoction in Treating Essential Hypertension of the Elder;补肾降压饮治疗老年高血压病的临床研究
16.Clinical Research on Kang Ping Antihypertension Capsule(KPAC) Treating Hypertension and Left Ventricular Hypertrophy;康平降压胶囊治疗高血压左室肥厚的临床研究
17.Clinical Research on Qing Gan Antihypertension Granule (QGAG) Treating Essential Hypertension;清肝降压颗粒治疗原发性高血压病的临床研究
18.The Clinic Study on Treatment of Tuchongjiangya Compound Tablet to Hyptertension;复方杜仲降压片治疗高血压病的临床研究
相关短句/例句
decreasing formation fracturing pressure降低地层破裂压力
3)pressure drop床层压降
1.There is a problem ofpressure drop rising during coker gasoline hydrorefining in the catalyst beds of unit1-B of SINOPEC Guangzhou Company.广州分公司加氢精制(一)B装置在进行焦化汽油加氢精制过程中存在催化剂床层压降升高过快的问题。
2.The influence of the stirrer speed and the blade shape on the fluidization in the stirred gas-solid fluidized beds was experimentally studied by examining the relationship between thepressure drop and superficial gas velocity.在流态化阶段,床层压降保持定值,该定值与搅拌转速和叶片形式没有关系。
3.Thepressure drop and two dimensional temperature profiles of a new hollow cylindrical vinyl acetate synthesis catalyst were measured in packed bed, and active ingredients were maldistributed on the inner and outside surface of this hollow cylinder.实验测定了一种新型的环柱形催化剂活性组分在其内、外表面上不均匀分布的乙烯基乙酸酯合成反应器的床层压降和该催化剂填充床的二维温度分布 ;以压降实验数据代入 Ergun公式计算了环柱形催化剂的当量直径 ds和填充床的传热参数 ,采用正交配置的方法对拟均相二维传热模型进行求解 ,得到床层的径向有效导热系数和壁给热系数。
4)bed pressure drop床层压降
1.The plots ofbed pressure drop of fluidized bed were established and then the effects of feed rate,temperature of entering drying air,flow rate of entering drying air,and diameter of inert particles on the heat transfer performance of the(drier) were studied in detail.测定了流化床的床层压降曲线,考察了进料量、进风温度、进风速度及惰性粒子直径对于流化床传热性能的影响,且与气体分布板开斜孔的传热性能进行了初步比较。
2.In an aerated spouted bed with a draft tube made of polymethylmethacrylate with internal diameter 92 mm, the glass beads used as experimental material, under the different aerating velocity, aerating position, punching rate, thebed pressure drop and particles down moving rate in the annulus were studied.在直径 92mm的有机玻璃制的带导向管的充气喷动床中 ,以玻璃珠为实验物料 ,在不同的充气量、不同充气位置、导向管不同开孔率条件下 ,对充气喷动床的床层压降和颗粒在环形区的下移速度进行研究 。
3.With the floater of power plant as the bed material to conduet cold state modelling experiment under the steady operation condition of furnace,the systematic study included:the relation of fluidized air velocity,bed pressure drop and height of bed material of bottom ash cooler;the effects of ash inl.以某电厂410t/h循环流化床锅炉(CFB)的选择性流化床冷渣器为原型,利用几何相似原理按1∶10的比例建立了可视化冷态试验装置,采用电厂漂珠作为床料进行冷态模化试验,系统研究了在炉膛稳定运行的情况下冷渣器的流化风速与床层压降和床料量之间的关系、冷渣器进渣管流化风量对床料由炉膛进入冷渣器的流动速率的影响。
5)drawdown zone压降层
6)settlement stratum沉降地层
1.Study on distributing rule of additional force of compressible shaft wall in hydrophobicsettlement stratum;疏水沉降地层竖向可缩性井壁附加力分布规律研究
延伸阅读
注射用降纤酶, 降纤酶, 龙津注射用降纤酶药物名称：注射用降纤酶英文名：Defibrase别名：注射用降纤酶, 降纤酶, 龙津注射用降纤酶外文名：Defibrase for Injection, Defibrase性状：本品为白色或类白色冻干块状物或粉末，有引湿性，易溶于水。药理毒理：蛋白水解酶。能溶解血栓，抑制血栓形成，改善微循环。适应症：（1）急性脑梗死，包括脑血栓、脑栓塞，短暂性脑缺血发作（TIA），以及脑梗死再复发的预防。（2）心肌梗死，不稳定性心绞痛以及心肌梗死再复发的预防。（3）四肢血管病，包括股动脉栓塞，血栓闭塞性脉管炎，雷诺氏病。（4）血液呈高粘状态、高凝状态、血栓前状态。（5）突发性耳聋。（6）肺栓塞。用法用量：临用前，用注射用水或生理盐水适量使之溶解，加入至无菌生理盐水100ml－250ml中，静脉点滴1小时以上。急性发作期：一次10单位，一日1次，连用3～4日。非急性发作期：首次10单位，维持量5～10单位，一日或隔日1次，二周为一疗程。不良反应：个别病人用药后可能出现少量淤斑、鼻血或牙龈出血、或有一过性GOT或GPT轻度上升，停药后自行消失。禁忌：有内源性出血倾向、过敏体质患者慎用。严重肝、肾功能不全患者禁用。（1）下列患者禁用①具有出血疾病史者。②手术后不久者。③有出血倾向者。④正在使用具有抗凝作用及抑制血小板功能药物（如：阿司匹林）者。⑤正在使用具有抗纤溶作用制剂者。⑥重度肝或肾功能障碍及其它如乳头肌断裂、心室中隔穿孔、心源性休克，多脏器功能衰竭症者。⑦ 对本制剂有过敏史者。（2）下列患者慎用① 有药物过敏史者。② 有消化道溃疡病史者。③ 患有脑血栓后遗症者。④ 70岁以上高龄患者。注意事项：（1）按专业医生处方购买和使用。（2）本品如有外观异常或瓶子破裂、过期失效等情况不可使用。（3）本品必须用足够量的输液稀释，并立即使用。（4）注意静脉点滴速度（点滴速度过快时，患者易有胸痛、心悸等不适症状）。（5）本制剂具有降低纤维蛋白原（fibrinogen）的作用，用药后可能有出血或止血延缓现象。因此，治疗前及给药期间应对患者进行血纤维蛋白原和其它出血及凝血功能的检查，并密切注意临床症状。给药治疗期间一旦出现出血和可疑出血时，应中止给药，并采取输血或其它措施。（6）如患者动脉或深部静脉损伤时，该药有可能引起血肿。因此，使用本制剂后，临床应避免进行如星状神经节封闭、动脉或深部静脉等的穿刺检查或治疗。对于浅表静脉穿刺部位有止血延缓现象发生时，应采用压迫止血法。孕妇及哺乳期妇女用药：妊娠期或有妊娠可能性的妇女，使用本药时，应在治疗上有益性大于危险才能使用；哺乳期一般应避免使用本制剂，如果必须使用本制剂时应停止哺乳。儿童用药：本制剂对儿童用药后的安全性尚未进行实验研究。药物相互作用：使用本品应避免与水杨酸类药物（如阿司匹林）合用。抗凝血药可加强本品作用，引起意外出血；抗纤溶药可抵消本品作用，禁止联用。规格：5单位；10单位类别：抗凝血药和溶血栓药
